Selective serotonin reuptake inhibitor escitalopram inhibits 5-HT(3) receptor currents in NCB-20 cells

Escitalopram is one of selective serotonin reuptake inhibitor antidepressants. As an S-enantiomer of citalopram, it shows better therapeutic outcome in depression and anxiety disorder treatment because it has higher selectivity for serotonin reuptake transporter than citalopram. The objective of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Yong Soo, Sung, Ki-Wug
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Physiological Society and The Korean Society of Pharmacology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819908/
https://www.ncbi.nlm.nih.gov/pubmed/31680773
http://dx.doi.org/10.4196/kjpp.2019.23.6.509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819908/
https://www.ncbi.nlm.nih.gov/pubmed/31680773
http://dx.doi.org/10.4196/kjpp.2019.23.6.509

Ejemplares similares